Secondary ischemic stroke prevention in patients with atrial fibrillation: results of the ROCKET AF study
https://doi.org/10.21518/2079-701X-2014-5-6-11
Abstract
The article tells about prevention of ischemic stroke (IS) in patients after IS or transient ischemic attack (TIA) against a background of non-valvular atrial fibrillation (AF). Anticoagulation therapy variants for secondary IS prevention in AF are evaluated, such as vitamin K antagonist warfarin and novel oral anticoagulants: inhibitor of coagulation factor Xa rivaroxaban, apixaban, and the direct thrombin inhibitor dabigatran. There are results of a ROCKET AF subanalysis which compared rivaroxaban and warfarin in patients with AF after IS or TIA. It is noted that widespread clinical use of oral anticoagulants for atrial fibrillation could result in a significant reduction of IS morbidity and mortality in this country.
Keywords
вторичная профилактика ишемического инсульта,
фибрилляция предсердий,
пероральные антикоагулянты,
апиксабан,
дабигатран,
ривароксабан,
субанализ исследования ROCKET AF,
secondary prevention of ischemic stroke,
atrial fibrillation,
oral anticoagulants,
apixaban,
dabigatran,
rivaroxaban,
ROCKET AF subanalysis
About the Authors
V. A. Parfyonov
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
S. V. Verbitskaya
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
References
1. Скворцова В.И., Губский Л.В., Стаховская Л.В. и др. Ишемический инсульт. В кн. «Неврология, национальное руководство». Под ред. Е.И. Гусева, А.И. Коновалова, В.И. Скворцовой. М.: ГЭОТАР-МЕДИА, 2009. С. 592-615.
2. Суслина З.А., Фонякин А.В., Гераскина Л.А. и др. Практическая кардионеврология. М.: ИМА-ПРЕСС, 2010.
3. Парфенов В.А., Хасанова Д.Р. Ишемический инсульт. М.: МИА, 2012.
4. Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37: 577-617.
5. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis, 2008, 25: 457-507.
6. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2011, 42: 227-276.
7. Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ. М., 2012.
8. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146: 857-867.
9. Heidbuchel H, Verhamme P, Alings M et al. European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace, 2013, 15: 625-651.
10. Connolly S, Ezekowitz MD, Ysuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med., 2009, 361: 1139-1151.
11. Patel М Mahaffey KW, Garg J et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med, 2011, 365: 883-891.
12. Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med, 2011, 365: 981-992.
13. Giugliano RP, Ruff CT, Braunwald E et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med, 2013, 369: 2093-2104.
14. Hankey GJ, Patel MR, Stevens SR. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. The Lancet Neurology, 2012, 11: 315-322.
15. Updated results of the prospective NOAC registry https://ash.confex.com/ash/2012/webprogram/Paper49970.html Beyer-Westendorf.
16. Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврологический журнал, 2011, 1: 17-21.
17. Шандалин В.А., Фонякин А.В., Гераскина Л.А. Вторичная профилактика ишемического инсульта: от рекомендаций - к реальной клинической практике. Журнал неврологии, нейропсихиатрии и психосоматики, 2012, 2: 35-41.
Review
For citations:
Parfyonov VA, Verbitskaya SV. Secondary ischemic stroke prevention in patients with atrial fibrillation: results of the ROCKET AF study. Meditsinskiy sovet = Medical Council. 2014;(5):6-11. (In Russ.) https://doi.org/10.21518/2079-701X-2014-5-6-11
Views:
547
Email this article 